8-K - Tenaya Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Delisting

Management Change

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

3.01

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 28, 2026, Tenaya Therapeutics, Inc. (the “Compan

Delisting

$1.00$1.00

5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective Jan

Management Change

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Tenaya Therapeutics, Inc. 2024 Inducement Equity Incentive Plan, as amended, and r

Exhibits Only

Exhibits (2)

10.1

EX-10.1

8-K